Přístupnostní navigace
E-application
Search Search Close
Publication detail
KRIKAVOVA, R. ROMANOVOVA, M. JENDZELOVSKA, Z. MAJERNIK,M. MASARYK, L. ZOUFALÝ, P. MILDE, M. MONCOL, J. HERCHEL, R. JENDZELOVSKY, R. NEMEC, I.
Original Title
Impact of the central atom and halido ligand on the structure, antiproliferative activity and selectivity of half-sandwich Ru(ii) and Ir(iii) complexes with a 1,3,4-thiadiazole-based ligand
Type
journal article in Web of Science
Language
English
Original Abstract
Half-sandwich complexes [Ru(?(6)-pcym)(L1)X]PF6 (1, 3) and [Ir(?(5)-Cp*)(L1)X]PF6 (2, 4) featuring a thiadiazole-based ligand L1 (2-(furan-2-yl)-5-(pyridin-2-yl)-1,3,4-thiadiazole) were synthesized and characterized by varied analytical methods, including single-crystal X-ray diffraction (X = Cl or I, pcym = p-cymene, Cp* = pentamethylcyclopentadienyl). The structures of the molecules were analysed and interpreted using computational methods such as Density Functional Theory (DFT) and Quantum Theory of Atoms in Molecules (QT-AIM). A H-1 NMR spectroscopy study showed that complexes 1-3 exhibited hydrolytic stability while 4 underwent partial iodido/chlorido ligand exchange in phosphate-buffered saline. Moreover, 1-4 demonstrated the ability to oxidize NADH (reduced nicotinamide adenine dinucleotide) to NAD(+) with Ir(iii) complexes 2 and 4 displaying higher catalytic activity compared to their Ru(ii) analogues. None of the complexes interacted with reduced glutathione (GSH). Additionally, 1-4 exhibited greater lipophilicity than cisplatin. In vitro biological analyses were performed in healthy cell lines (CCD-18Co colon and CCD-1072Sk foreskin fibroblasts) as well as in cisplatin-sensitive (A2780) and -resistant (A2780cis) ovarian cancer cell lines. The results indicated that Ir(iii) complexes 2 and 4 had no effect on human fibroblasts, demonstrating their selectivity. In contrast, complexes 1 and 4 exhibited moderate inhibitory effects on the metabolic and proliferation activities of the cancer cells tested (selectivity index SI > 3.4 for 4 and 2.6 for cisplatin; SI = IC50(A2780)/IC50(CCD-18Co)), including the cisplatin-resistant cancer cell line. Based on these findings, it is possible to emphasize that mainly complex 4 could represent a further step in the development of selective and highly effective anticancer agents, particularly against resistant tumour types.
Keywords
PHOTODYNAMIC THERAPY; ANTICANCER ACTIVITY; CANCER-CELLS; BASIS-SETS; RUTHENIUM; HYPERICIN; GLUTATHIONE; DESIGN; PSEUDOPOTENTIALS; CYTOTOXICITY
Authors
KRIKAVOVA, R.; ROMANOVOVA, M.; JENDZELOVSKA, Z.; MAJERNIK,M.; MASARYK, L.; ZOUFALÝ, P.; MILDE, M.; MONCOL, J.; HERCHEL, R.; JENDZELOVSKY, R.; NEMEC, I.
Released
19. 9. 2023
Publisher
Royal Society of Chemistry
Location
CAMBRIDGE
ISBN
1477-9234
Periodical
Dalton Transactions
Year of study
52
Number
36
State
United Kingdom of Great Britain and Northern Ireland
Pages from
12717
Pages to
12732
Pages count
16
URL
https://pubs.rsc.org/en/content/articlelanding/2023/dt/d3dt01696j
Full text in the Digital Library
http://hdl.handle.net/11012/245058
BibTex
@article{BUT187389, author="Radka {Krikavova} and Michaela {Romanovová} and Zuzana {Jendželovská} and Martin {Majerník} and Lukáš {Masaryk} and Pavel {Zoufalý} and David {Milde} and Ján {Moncol} and Radovan {Herchel} and Rastislav {Jendželovský} and Ivan {Nemec}", title="Impact of the central atom and halido ligand on the structure, antiproliferative activity and selectivity of half-sandwich Ru(ii) and Ir(iii) complexes with a 1,3,4-thiadiazole-based ligand", journal="Dalton Transactions", year="2023", volume="52", number="36", pages="12717--12732", doi="10.1039/d3dt01696j", issn="1477-9234", url="https://pubs.rsc.org/en/content/articlelanding/2023/dt/d3dt01696j" }